Spotlight On... New molecule targets cancer stem cells; New mouse/human platform at Whitehead; and more...

Liang Fang and fellow researchers in Walter Birchmeier's group at the Max Delbrück Center for Molecular Medicine led a team with colleagues at the Berlin-Buch campus which discovered a molecule that interrupts biochemical signals essential for the survival of a "certain type of cancer stem cell." Targeting cancer item cells has been a growing field in oncology. The work is published ahead of print in the online edition of Cancer Research. Release

> Researchers at the Whitehead Institute created a new mouse-human modeling platform that could be used to study neural crest development as well as cancers such as melanoma and neurofibromatosis. Release

> Scientists at the University of Wisconsin-Madison have been tracking the development of different strains of the Zika virus, part of a widespread effort now underway to better understand Zika and develop a new vaccine to stop it. Release

Suggested Articles

Brigham and Women’s Hospital scientists linked a noncoding RNA to atherosclerosis in a discovery that could aid in the development of new heart drugs.

Researchers discovered that inactivating a subtype of the protein beta-arrestin-2 in mice restored the ability of the brain to dispose of toxic tau.

A newfound link between BMAL1, a protein involved in circadian rhythms, and triple-negative breast cancer could point to new treatment strategies.